GO:0003674 | molecular_function | 81.58% (93/114) | 0.75 | 0.0 | 0.0 |
GO:0009987 | cellular process | 47.37% (54/114) | 1.25 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 23.68% (27/114) | 2.12 | 0.0 | 0.0 |
GO:0005575 | cellular_component | 32.46% (37/114) | 1.65 | 0.0 | 0.0 |
GO:0043226 | organelle | 16.67% (19/114) | 2.56 | 0.0 | 0.0 |
GO:0043229 | intracellular organelle | 16.67% (19/114) | 2.56 | 0.0 | 0.0 |
GO:0008150 | biological_process | 61.4% (70/114) | 0.9 | 0.0 | 0.0 |
GO:0044238 | primary metabolic process | 40.35% (46/114) | 1.31 | 0.0 | 0.0 |
GO:0005198 | structural molecule activity | 11.4% (13/114) | 3.21 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 33.33% (38/114) | 1.45 | 0.0 | 0.0 |
GO:0097159 | organic cyclic compound binding | 41.23% (47/114) | 1.21 | 0.0 | 0.0 |
GO:0005488 | binding | 57.89% (66/114) | 0.88 | 0.0 | 0.0 |
GO:0140097 | catalytic activity, acting on DNA | 7.89% (9/114) | 4.01 | 0.0 | 0.0 |
GO:0071704 | organic substance metabolic process | 40.35% (46/114) | 1.19 | 0.0 | 0.0 |
GO:1903047 | mitotic cell cycle process | 4.39% (5/114) | 6.02 | 0.0 | 0.0 |
GO:0035639 | purine ribonucleoside triphosphate binding | 23.68% (27/114) | 1.73 | 0.0 | 1e-06 |
GO:0006807 | nitrogen compound metabolic process | 34.21% (39/114) | 1.31 | 0.0 | 1e-06 |
GO:0008152 | metabolic process | 41.23% (47/114) | 1.12 | 0.0 | 1e-06 |
GO:0051082 | unfolded protein binding | 5.26% (6/114) | 4.88 | 0.0 | 1e-06 |
GO:0005524 | ATP binding | 21.93% (25/114) | 1.75 | 0.0 | 2e-06 |
GO:0006259 | DNA metabolic process | 8.77% (10/114) | 3.28 | 0.0 | 2e-06 |
GO:0003676 | nucleic acid binding | 23.68% (27/114) | 1.62 | 0.0 | 2e-06 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 10.53% (12/114) | 2.84 | 0.0 | 3e-06 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 10.53% (12/114) | 2.83 | 0.0 | 3e-06 |
GO:0051276 | chromosome organization | 5.26% (6/114) | 4.65 | 0.0 | 3e-06 |
GO:0007076 | mitotic chromosome condensation | 2.63% (3/114) | 7.74 | 0.0 | 3e-06 |
GO:1901265 | nucleoside phosphate binding | 25.44% (29/114) | 1.5 | 0.0 | 3e-06 |
GO:0000166 | nucleotide binding | 25.44% (29/114) | 1.5 | 0.0 | 3e-06 |
GO:0017076 | purine nucleotide binding | 24.56% (28/114) | 1.53 | 0.0 | 4e-06 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 10.53% (12/114) | 2.75 | 0.0 | 4e-06 |
GO:0032555 | purine ribonucleotide binding | 23.68% (27/114) | 1.55 | 0.0 | 4e-06 |
GO:0032553 | ribonucleotide binding | 23.68% (27/114) | 1.53 | 0.0 | 5e-06 |
GO:0006412 | translation | 8.77% (10/114) | 3.06 | 0.0 | 5e-06 |
GO:0003735 | structural constituent of ribosome | 8.77% (10/114) | 3.03 | 0.0 | 6e-06 |
GO:0043043 | peptide biosynthetic process | 8.77% (10/114) | 3.03 | 0.0 | 6e-06 |
GO:0097367 | carbohydrate derivative binding | 23.68% (27/114) | 1.52 | 0.0 | 6e-06 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 9.65% (11/114) | 2.83 | 0.0 | 6e-06 |
GO:1901363 | heterocyclic compound binding | 25.44% (29/114) | 1.45 | 0.0 | 6e-06 |
GO:0030261 | chromosome condensation | 2.63% (3/114) | 7.42 | 0.0 | 6e-06 |
GO:0016887 | ATP hydrolysis activity | 7.89% (9/114) | 3.24 | 1e-06 | 6e-06 |
GO:0036094 | small molecule binding | 25.44% (29/114) | 1.44 | 1e-06 | 6e-06 |
GO:0044237 | cellular metabolic process | 30.7% (35/114) | 1.24 | 1e-06 | 6e-06 |
GO:0030554 | adenyl nucleotide binding | 22.81% (26/114) | 1.54 | 1e-06 | 7e-06 |
GO:0006518 | peptide metabolic process | 8.77% (10/114) | 2.96 | 1e-06 | 8e-06 |
GO:0090304 | nucleic acid metabolic process | 14.04% (16/114) | 2.13 | 1e-06 | 8e-06 |
GO:0043604 | amide biosynthetic process | 8.77% (10/114) | 2.94 | 1e-06 | 8e-06 |
GO:0016462 | pyrophosphatase activity | 9.65% (11/114) | 2.75 | 1e-06 | 8e-06 |
GO:0032559 | adenyl ribonucleotide binding | 21.93% (25/114) | 1.56 | 1e-06 | 8e-06 |
GO:0005515 | protein binding | 28.95% (33/114) | 1.26 | 1e-06 | 1.1e-05 |
GO:0016787 | hydrolase activity | 21.05% (24/114) | 1.57 | 1e-06 | 1.2e-05 |
GO:0043232 | intracellular non-membrane-bounded organelle | 8.77% (10/114) | 2.81 | 2e-06 | 1.6e-05 |
GO:0043228 | non-membrane-bounded organelle | 8.77% (10/114) | 2.81 | 2e-06 | 1.6e-05 |
GO:0043603 | amide metabolic process | 8.77% (10/114) | 2.8 | 2e-06 | 1.7e-05 |
GO:0032991 | protein-containing complex | 14.04% (16/114) | 2.0 | 3e-06 | 2.2e-05 |
GO:0043168 | anion binding | 23.68% (27/114) | 1.39 | 3e-06 | 2.3e-05 |
GO:0006139 | nucleobase-containing compound metabolic process | 14.91% (17/114) | 1.89 | 3e-06 | 2.6e-05 |
GO:0110165 | cellular anatomical entity | 21.05% (24/114) | 1.48 | 4e-06 | 3e-05 |
GO:0006457 | protein folding | 5.26% (6/114) | 3.84 | 4e-06 | 3.4e-05 |
GO:1901360 | organic cyclic compound metabolic process | 15.79% (18/114) | 1.78 | 5e-06 | 3.8e-05 |
GO:0006260 | DNA replication | 4.39% (5/114) | 4.3 | 6e-06 | 4.4e-05 |
GO:0006270 | DNA replication initiation | 2.63% (3/114) | 6.28 | 7e-06 | 5.3e-05 |
GO:0005634 | nucleus | 7.89% (9/114) | 2.74 | 9e-06 | 6.7e-05 |
GO:0046483 | heterocycle metabolic process | 14.91% (17/114) | 1.75 | 1.1e-05 | 8.3e-05 |
GO:0022402 | cell cycle process | 4.39% (5/114) | 4.05 | 1.4e-05 | 0.0001 |
GO:1901576 | organic substance biosynthetic process | 14.04% (16/114) | 1.8 | 1.4e-05 | 0.000101 |
GO:0006725 | cellular aromatic compound metabolic process | 14.91% (17/114) | 1.72 | 1.5e-05 | 0.000103 |
GO:0005840 | ribosome | 7.02% (8/114) | 2.88 | 1.5e-05 | 0.000103 |
GO:0009059 | macromolecule biosynthetic process | 9.65% (11/114) | 2.28 | 1.8e-05 | 0.000121 |
GO:0044249 | cellular biosynthetic process | 13.16% (15/114) | 1.81 | 2.5e-05 | 0.000167 |
GO:0003887 | DNA-directed DNA polymerase activity | 2.63% (3/114) | 5.57 | 3.3e-05 | 0.000219 |
GO:0009058 | biosynthetic process | 14.04% (16/114) | 1.7 | 3.3e-05 | 0.000221 |
GO:0034061 | DNA polymerase activity | 2.63% (3/114) | 5.49 | 3.9e-05 | 0.000256 |
GO:0140657 | ATP-dependent activity | 7.89% (9/114) | 2.44 | 4.5e-05 | 0.000288 |
GO:0043227 | membrane-bounded organelle | 7.89% (9/114) | 2.33 | 8.4e-05 | 0.000523 |
GO:0043231 | intracellular membrane-bounded organelle | 7.89% (9/114) | 2.33 | 8.4e-05 | 0.000523 |
GO:0003678 | DNA helicase activity | 2.63% (3/114) | 5.04 | 0.000104 | 0.000639 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 9.65% (11/114) | 1.98 | 0.000115 | 0.000702 |
GO:0016779 | nucleotidyltransferase activity | 4.39% (5/114) | 3.4 | 0.000118 | 0.000711 |
GO:0008097 | 5S rRNA binding | 1.75% (2/114) | 6.83 | 0.000122 | 0.000722 |
GO:0030120 | vesicle coat | 2.63% (3/114) | 4.88 | 0.000144 | 0.000847 |
GO:0043167 | ion binding | 27.19% (31/114) | 0.96 | 0.000159 | 0.000919 |
GO:1901566 | organonitrogen compound biosynthetic process | 8.77% (10/114) | 2.03 | 0.000178 | 0.001018 |
GO:0006996 | organelle organization | 5.26% (6/114) | 2.85 | 0.000193 | 0.001089 |
GO:0042555 | MCM complex | 1.75% (2/114) | 6.35 | 0.000254 | 0.001419 |
GO:0003723 | RNA binding | 8.77% (10/114) | 1.96 | 0.000261 | 0.001438 |
GO:0019538 | protein metabolic process | 19.3% (22/114) | 1.16 | 0.00027 | 0.001473 |
GO:0004520 | DNA endonuclease activity | 1.75% (2/114) | 6.15 | 0.000338 | 0.001802 |
GO:0006508 | proteolysis | 7.89% (9/114) | 2.06 | 0.000335 | 0.001806 |
GO:0008094 | ATP-dependent activity, acting on DNA | 3.51% (4/114) | 3.55 | 0.00039 | 0.002054 |
GO:0032508 | DNA duplex unwinding | 1.75% (2/114) | 5.98 | 0.000434 | 0.002235 |
GO:0032392 | DNA geometric change | 1.75% (2/114) | 5.98 | 0.000434 | 0.002235 |
GO:0030117 | membrane coat | 2.63% (3/114) | 4.28 | 0.000504 | 0.002569 |
GO:0003824 | catalytic activity | 37.72% (43/114) | 0.66 | 0.00066 | 0.003291 |
GO:0004536 | DNA nuclease activity | 1.75% (2/114) | 5.69 | 0.00066 | 0.003326 |
GO:0004386 | helicase activity | 3.51% (4/114) | 3.31 | 0.000741 | 0.003657 |
GO:1901564 | organonitrogen compound metabolic process | 21.05% (24/114) | 0.99 | 0.000766 | 0.00374 |
GO:0030126 | COPI vesicle coat | 1.75% (2/114) | 5.57 | 0.00079 | 0.003818 |
GO:0008233 | peptidase activity | 7.02% (8/114) | 2.03 | 0.000824 | 0.003945 |
GO:0003777 | microtubule motor activity | 2.63% (3/114) | 3.98 | 0.00092 | 0.004315 |
GO:0007018 | microtubule-based movement | 2.63% (3/114) | 3.98 | 0.00092 | 0.004315 |
GO:0005852 | eukaryotic translation initiation factor 3 complex | 1.75% (2/114) | 5.15 | 0.001423 | 0.006606 |
GO:0003774 | cytoskeletal motor activity | 2.63% (3/114) | 3.69 | 0.001646 | 0.00757 |
GO:0008234 | cysteine-type peptidase activity | 3.51% (4/114) | 2.97 | 0.001747 | 0.007953 |
GO:0008610 | lipid biosynthetic process | 4.39% (5/114) | 2.5 | 0.002007 | 0.00905 |
GO:0071103 | DNA conformation change | 1.75% (2/114) | 4.69 | 0.002701 | 0.012064 |
GO:0051603 | proteolysis involved in protein catabolic process | 3.51% (4/114) | 2.77 | 0.002913 | 0.01289 |
GO:0071216 | cellular response to biotic stimulus | 0.88% (1/114) | 8.15 | 0.003514 | 0.013735 |
GO:0101031 | protein folding chaperone complex | 0.88% (1/114) | 8.15 | 0.003514 | 0.013735 |
GO:0005832 | chaperonin-containing T-complex | 0.88% (1/114) | 8.15 | 0.003514 | 0.013735 |
GO:0072396 | response to cell cycle checkpoint signaling | 0.88% (1/114) | 8.15 | 0.003514 | 0.013735 |
GO:0072402 | response to DNA integrity checkpoint signaling | 0.88% (1/114) | 8.15 | 0.003514 | 0.013735 |
GO:0072423 | response to DNA damage checkpoint signaling | 0.88% (1/114) | 8.15 | 0.003514 | 0.013735 |
GO:0033567 | DNA replication, Okazaki fragment processing | 0.88% (1/114) | 8.15 | 0.003514 | 0.013735 |
GO:1902315 | nuclear cell cycle DNA replication initiation | 0.88% (1/114) | 8.15 | 0.003514 | 0.013735 |
GO:1902975 | mitotic DNA replication initiation | 0.88% (1/114) | 8.15 | 0.003514 | 0.013735 |
GO:0071495 | cellular response to endogenous stimulus | 0.88% (1/114) | 8.15 | 0.003514 | 0.013735 |
GO:0017116 | single-stranded DNA helicase activity | 0.88% (1/114) | 8.15 | 0.003514 | 0.013735 |
GO:1902292 | cell cycle DNA replication initiation | 0.88% (1/114) | 8.15 | 0.003514 | 0.013735 |
GO:0048532 | anatomical structure arrangement | 0.88% (1/114) | 8.15 | 0.003514 | 0.013735 |
GO:0009933 | meristem structural organization | 0.88% (1/114) | 8.15 | 0.003514 | 0.013735 |
GO:1990904 | ribonucleoprotein complex | 3.51% (4/114) | 2.63 | 0.004116 | 0.015956 |
GO:0008092 | cytoskeletal protein binding | 3.51% (4/114) | 2.61 | 0.004277 | 0.016442 |
GO:0016043 | cellular component organization | 6.14% (7/114) | 1.78 | 0.004477 | 0.01707 |
GO:0008017 | microtubule binding | 2.63% (3/114) | 3.11 | 0.00519 | 0.019629 |
GO:0006426 | glycyl-tRNA aminoacylation | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:1905462 | regulation of DNA duplex unwinding | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:0004820 | glycine-tRNA ligase activity | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:0032780 | negative regulation of ATP-dependent activity | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:0048256 | flap endonuclease activity | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:0000796 | condensin complex | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:0000082 | G1/S transition of mitotic cell cycle | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:0043462 | regulation of ATP-dependent activity | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:1905463 | negative regulation of DNA duplex unwinding | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:0051095 | regulation of helicase activity | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:0051097 | negative regulation of helicase activity | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:0017108 | 5'-flap endonuclease activity | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:1905775 | negative regulation of DNA helicase activity | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:1905774 | regulation of DNA helicase activity | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:0016442 | RISC complex | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:0031332 | RNAi effector complex | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:0044770 | cell cycle phase transition | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:0016885 | ligase activity, forming carbon-carbon bonds | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:0044772 | mitotic cell cycle phase transition | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:0044843 | cell cycle G1/S phase transition | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:0003989 | acetyl-CoA carboxylase activity | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:0016421 | CoA carboxylase activity | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:0006427 | histidyl-tRNA aminoacylation | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:0004821 | histidine-tRNA ligase activity | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:0006515 | protein quality control for misfolded or incompletely synthesized proteins | 0.88% (1/114) | 7.15 | 0.007016 | 0.021792 |
GO:0019843 | rRNA binding | 1.75% (2/114) | 3.98 | 0.007134 | 0.021868 |
GO:0015631 | tubulin binding | 2.63% (3/114) | 2.94 | 0.00712 | 0.021968 |
GO:0044255 | cellular lipid metabolic process | 4.39% (5/114) | 2.13 | 0.005984 | 0.022454 |
GO:0007017 | microtubule-based process | 2.63% (3/114) | 2.87 | 0.008224 | 0.025046 |
GO:0071840 | cellular component organization or biogenesis | 6.14% (7/114) | 1.61 | 0.008377 | 0.025346 |
GO:0006629 | lipid metabolic process | 5.26% (6/114) | 1.77 | 0.008656 | 0.026024 |
GO:0003677 | DNA binding | 9.65% (11/114) | 1.19 | 0.008819 | 0.026346 |
GO:0046907 | intracellular transport | 3.51% (4/114) | 2.28 | 0.00963 | 0.028586 |
GO:0051649 | establishment of localization in cell | 3.51% (4/114) | 2.26 | 0.009912 | 0.029237 |
GO:0000737 | obsolete DNA catabolic process, endonucleolytic | 0.88% (1/114) | 6.57 | 0.010506 | 0.029683 |
GO:0005689 | U12-type spliceosomal complex | 0.88% (1/114) | 6.57 | 0.010506 | 0.029683 |
GO:0009008 | DNA-methyltransferase activity | 0.88% (1/114) | 6.57 | 0.010506 | 0.029683 |
GO:0090116 | C-5 methylation of cytosine | 0.88% (1/114) | 6.57 | 0.010506 | 0.029683 |
GO:0003886 | DNA (cytosine-5-)-methyltransferase activity | 0.88% (1/114) | 6.57 | 0.010506 | 0.029683 |
GO:0032776 | DNA methylation on cytosine | 0.88% (1/114) | 6.57 | 0.010506 | 0.029683 |
GO:0004576 | oligosaccharyl transferase activity | 0.88% (1/114) | 6.57 | 0.010506 | 0.029683 |
GO:0009057 | macromolecule catabolic process | 3.51% (4/114) | 2.18 | 0.012194 | 0.034245 |
GO:0016579 | protein deubiquitination | 1.75% (2/114) | 3.54 | 0.012928 | 0.03609 |
GO:0004843 | cysteine-type deubiquitinase activity | 1.75% (2/114) | 3.51 | 0.013436 | 0.037286 |
GO:0032543 | mitochondrial translation | 0.88% (1/114) | 6.15 | 0.013984 | 0.03791 |
GO:0016889 | DNA endonuclease activity, producing 3'-phosphomonoesters | 0.88% (1/114) | 6.15 | 0.013984 | 0.03791 |
GO:0008821 | crossover junction DNA endonuclease activity | 0.88% (1/114) | 6.15 | 0.013984 | 0.03791 |
GO:0070646 | protein modification by small protein removal | 1.75% (2/114) | 3.48 | 0.013952 | 0.038492 |
GO:0004518 | nuclease activity | 2.63% (3/114) | 2.56 | 0.014661 | 0.039518 |
GO:0006886 | intracellular protein transport | 2.63% (3/114) | 2.53 | 0.01548 | 0.041486 |
GO:0006418 | tRNA aminoacylation for protein translation | 1.75% (2/114) | 3.37 | 0.016103 | 0.041958 |
GO:0004812 | aminoacyl-tRNA ligase activity | 1.75% (2/114) | 3.37 | 0.016103 | 0.041958 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 1.75% (2/114) | 3.37 | 0.016103 | 0.041958 |
GO:0043038 | amino acid activation | 1.75% (2/114) | 3.37 | 0.016103 | 0.041958 |
GO:0043039 | tRNA aminoacylation | 1.75% (2/114) | 3.37 | 0.016103 | 0.041958 |
GO:0043632 | modification-dependent macromolecule catabolic process | 2.63% (3/114) | 2.49 | 0.016611 | 0.04257 |
GO:0019941 | modification-dependent protein catabolic process | 2.63% (3/114) | 2.49 | 0.016611 | 0.04257 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 2.63% (3/114) | 2.49 | 0.016611 | 0.04257 |
GO:0046168 | glycerol-3-phosphate catabolic process | 0.88% (1/114) | 5.83 | 0.017449 | 0.042624 |
GO:0032977 | membrane insertase activity | 0.88% (1/114) | 5.83 | 0.017449 | 0.042624 |
GO:0140597 | protein carrier chaperone | 0.88% (1/114) | 5.83 | 0.017449 | 0.042624 |
GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters | 0.88% (1/114) | 5.83 | 0.017449 | 0.042624 |
GO:0000278 | mitotic cell cycle | 0.88% (1/114) | 5.83 | 0.017449 | 0.042624 |
GO:0016297 | acyl-[acyl-carrier-protein] hydrolase activity | 0.88% (1/114) | 5.83 | 0.017449 | 0.042624 |
GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity | 0.88% (1/114) | 5.83 | 0.017449 | 0.042624 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 0.88% (1/114) | 5.83 | 0.017449 | 0.042624 |
GO:0046337 | phosphatidylethanolamine metabolic process | 0.88% (1/114) | 5.83 | 0.017449 | 0.042624 |
GO:0016874 | ligase activity | 2.63% (3/114) | 2.45 | 0.017787 | 0.043222 |
GO:0004519 | endonuclease activity | 1.75% (2/114) | 3.27 | 0.018386 | 0.044449 |
GO:0004175 | endopeptidase activity | 3.51% (4/114) | 1.97 | 0.01962 | 0.047189 |
GO:0101005 | deubiquitinase activity | 1.75% (2/114) | 3.2 | 0.020183 | 0.048294 |
GO:0009331 | glycerol-3-phosphate dehydrogenase complex | 0.88% (1/114) | 5.57 | 0.020903 | 0.049264 |
GO:0009360 | DNA polymerase III complex | 0.88% (1/114) | 5.57 | 0.020903 | 0.049264 |
GO:0006633 | fatty acid biosynthetic process | 1.75% (2/114) | 3.18 | 0.020797 | 0.049512 |